Form 603, “Notice of initial substantial holder” was lodged with the Australian Securities Exchange on 30th January at 5:25 PM.
View the Form 603.
Chairman’s Address to Shareholders and Q&A Session at 2023 Annual General Meeting
Imagion Biosystems’ Chairman’s address to shareholders at the 2023 Annual General Meeting. PDF of the 2023 AGM Presentation Deck Watch the AGM 2023 Q&A Session